Literature DB >> 32268861

Exploiting Anti-Inflammation Effects of Flavonoids in Chronic Inflammatory Diseases.

Tarique Hussain1,2, Ghulam Murtaza3, Huansheng Yang4, Muhammad S Kalhoro5, Dildar H Kalhoro6.   

Abstract

BACKGROUND: Inflammation is a complex response of the host defense system to different internal and external stimuli. It is believed that persistent inflammation may lead to chronic inflammatory diseases such as, inflammatory bowel disease, neurological and cardiovascular diseases. Oxidative stress is the main factor responsible for the augmentation of inflammation via various molecular pathways. Therefore, alleviating oxidative stress is effective a therapeutic option against chronic inflammatory diseases.
METHODS: This review article extends the knowledge of the regulatory mechanisms of flavonoids targeting inflammatory pathways in chronic diseases, which would be the best approach for the development of suitable therapeutic agents against chronic diseases.
RESULTS: Since the inflammatory response is initiated by numerous signaling molecules like NF-κB, MAPK, and Arachidonic acid pathways, their encountering function can be evaluated with the activation of Nrf2 pathway, a promising approach to inhibit/prevent chronic inflammatory diseases by flavonoids. Over the last few decades, flavonoids drew much attention as a potent alternative therapeutic agent. Recent clinical evidence has shown significant impacts of flavonoids on chronic diseases in different in-vivo and in-vitro models.
CONCLUSION: Flavonoid compounds can interact with chronic inflammatory diseases at the cellular level and modulate the response of protein pathways. A promising approach is needed to overlook suitable alternative compounds providing more therapeutic efficacy and exerting fewer side effects than commercially available antiinflammatory drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Chronic inflammatory diseases; anti-inflammation effects; arachidonic; flavonoids; neurological; therapeutic

Year:  2020        PMID: 32268861     DOI: 10.2174/1381612826666200408101550

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  SETD4 in the Proliferation, Migration, Angiogenesis, Myogenic Differentiation and Genomic Methylation of Bone Marrow Mesenchymal Stem Cells.

Authors:  Xiaomin Liao; Caixia Wu; Zhongming Shao; Shuya Zhang; Yuan Zou; Keke Wang; Yanping Ha; Jingci Xing; Axiu Zheng; Zhihua Shen; Shaojiang Zheng; Junli Guo; Wei Jie
Journal:  Stem Cell Rev Rep       Date:  2021-01-27       Impact factor: 5.739

2.  Dietary Flavone Baicalein Combinate with Genipin Attenuates Inflammation Stimulated by Lipopolysaccharide in RAW264.7 Cells or Pseudomonas aeruginosa in Mice via Regulating the Expression and Phosphorylation of AKT.

Authors:  Man Zhang; Lili Ye; Chuanjing Cheng; Fukui Shen; Lin Niu; Yuanyuan Hou; Gang Bai
Journal:  Nutrients       Date:  2021-12-14       Impact factor: 5.717

3.  Editorial: The Role of Natural Products in Chronic Inflammation.

Authors:  Wenjun Deng; Hongzhi Du; Dahui Liu; Zhaocheng Ma
Journal:  Front Pharmacol       Date:  2022-04-29       Impact factor: 5.810

4.  Paclitaxel-Containing Extract Exerts Anti-Cancer Activity through Oral Administration in A549-Xenografted BALB/C Nude Mice: Synergistic Effect between Paclitaxel and Flavonoids or Lignoids.

Authors:  Dake Cai; Jing Jin; Huichang Bi; Guoping Zhong; Minhua Zhou; Jianfen Guo; Yike Cai; Miaoyin Liang; Qiong Gu; Zixuan Hu; Yijing Lai; Zi Dai; Lingjie Li; Yuxing Chen; Haili Gao; Min Huang
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-25       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.